Is informed consent to clinical trials an “upside selective” process in acute coronary syndromes?
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 140 (1) , 94-97
- https://doi.org/10.1067/mhj.2000.106625
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- The impact of disease severity on the informed consent process in clinical researchThe American Journal of Medicine, 1996
- Informed Consent in Emergency ResearchJAMA, 1989
- How informed is informed consent?Controlled Clinical Trials, 1981
- Informed Consent — Why Are Its Goals Imperfectly Realized?New England Journal of Medicine, 1980
- Informed consent: How much does the patient understand?Clinical Pharmacology & Therapeutics, 1980
- Myocardial infarction—Case studies of ethics in the consent situationSocial Science & Medicine (1967), 1974